Free Workshop for Media and Medical Writers on Covering Thyroid Cancer, October 16, 2014, from 4 to 5 p.m.09/2014
ThyCa: Thyroid Cancer Survivor’s Association will conduct a free workshop on “Covering Thyroid Cancer” on Thursday, October 16, 2014, from 4 p.m. to 5 p.m. as part of its 17th International Thyroid Cancer Survivors' Conference at the Doubletree by Hilton Denver Hotel, 3201 Quebec Street, Denver, Colorado.
Media representatives and medical writers are welcome. The workshop will include questions and answers and free materials, including the 50-page handbook Thyroid Cancer Basics (available in English, Chinese, and Spanish) plus the Anaplastic Thyroid Cancer Handbook and Medullary Thyroid Cancer Handbook.
Thyroid cancer survivors will be available for interviews. Journalism students are welcome.
Thyroid cancer has increased rapidly in incidence in recent years in both men and women. A total of 62,980 people will be diagnosed with thyroid cancer in the United States in 2014. Thyroid cancer is now the ninth most common cancer. It occurs in all age groups from young children through seniors. Three of every four people diagnosed are women. Thyroid cancer has several types and variants and is treated differently from other kinds of cancer.
The 17th International Thyroid Cancer Survivors’ Conference will take place on October 17-19, 2014, at the Doubletree by Hilton Denver Hotel, 3201 Quebec Street, Denver, Colorado, with over 100 sessions and 50 speakers, including 40 physicians and other specialists from numerous leading centers.
ThyCa: Thyroid Cancer Survivors' Association, Inc. s a non-profit 501(c)(3) organization of thyroid cancer survivors, family members, and health care professionals, founded in 1995 and dedicated to support, education, and communication for thyroid cancer survivors, their families and friends. ThyCa serves people worldwide and sponsors Thyroid Cancer Awareness Month, year-round awareness activities, free support groups and publications, the annual International Thyroid Cancer Survivors' Conference, and thyroid cancer research fundraising and research grants.